← Leaderboards
Sandra K Burchett
Children'S Hospital Boston
$1,312,188
Attributed
$1,312,188
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $425.5K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,312,188 · 8
By mechanism
P30$1,241,988 · 1
M01$70,200 · 7
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Raif Salim Geha$43,046,244
- Kenneth J McIntosh$8,678,025
- David S Ludwig$17,408,359
- Ellis J Neufeld$12,060,310
- Pedro J. Del Nido$21,875,670
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHiv InfectionsHuman Therapy EvaluationClinical ResearchPatient Oriented ResearchPediatric AidsAids TherapyProgramsPreventionRecordsHost Organism InteractionAreaDetectionBehavioralInstitutionDrug Screening /EvaluationCombination ChemotherapyFosteringCollaborationsAcquired Immunodeficiency SyndromeAids/Hiv ProblemDrug ResistanceFundingResearch Infrastructure
Grant awards (11)
Core--Developmental Facility$425,505
P30 · FY2008 · AI · contact PI
Core--Developmental Facility$414,183
P30 · FY2007 · AI · contact PI
Core--Developmental Facility$402,300
P30 · FY2006 · AI · contact PI
PACTG 1021:$7,350
M01 · FY2006 · RR · contact PI
PACTG 1015: HIV-SPECIFIC CD4 AND CD8 ACTIVITY BY RECYCLING HAART IN PEDS/ADOLES$5,514
M01 · FY2006 · RR · contact PI
PACTG 1045: PREVALENCE OF MORPHOLOGIC &METABOLIC ADNORMALITIES IN VERTICALLY$24,604
M01 · FY2005 · RR
PACTG 1015: HIV-SPECIFIC CD4 AND CD8 ACTIVITY BY RECYCLING HAART IN PEDS/ADOLES$16,918
M01 · FY2005 · RR
PACTG 1015: HIV-specific CD4 and CD8 activity by recycling HAART in peds/adoles.$10,820
M01 · FY2004 · RR
ACTG P1010: Effect of antiretroviral therapy on body composition in HIV-infecte$2,497
M01 · FY2004 · RR
PACTG 1030$1,664
M01 · FY2004 · RR
PACTG 1021:$833
M01 · FY2004 · RR